Change over period: —
NSE · NAVINFLUOR
NAVIN FLUORI
0.0% from the 52-week high · +84.8% above the low
Navin Flourine International Ltd. engages in the business of fluorine chemistry, manufacture of refrigeration gases, inorganic fluorides, and specialty organofluorines, and the provision of contract research and manufacturing services. The company is headquartered in Mumbai, Maharashtra and currently employs 1,053 full-time employees. The company went IPO on 2007-06-01. The firm operates through the Chemical Business segment. The company has two geographical segments based upon the location of its customers, which include within India and outside India. The company is the manufacturer of specialty fluorochemicals, which comprises synthetic cryolite, fluorocarbon gases, and hydrofluoric acid and other fluorine chemicals. The company offers contract research and manufacturing services. The firm has anhydrous hydrofluoric and diluted hydrofluoric acid manufacturing capacities in India with a multi-product portfolio. The company serves industries, including stainless steel, glass, oil and gas, abrasives, electronic products, and life and crop science, among others. The Company’s manufacturing facilities are located at Surat in Gujarat and Dewas in Madhya Pradesh.
The short version. NAVIN FLUORI reported revenue of ₹1,191 crore for Sep 2026, up 57.1% from a year earlier. Net profit was ₹269 crore (up 81.8% year on year). Return on equity was 16.7% in Mar 2026. Promoter holding was 27.08% in Sep 2026, down 1.36 points over 8 quarters.
1 · The price
How has the stock traded?
NAVIN FLUORI trades 0.0% at its 52-week high and 84.8% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹1,191 cr.
Sep 2026 net profit of ₹269 cr.
3.0 pts higher than a year earlier.
Revenue compounded at 16.9% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1191 | 1045 | 938 | 892 | 758 | 725 | 701 | 606 |
| Net profit | 269 | 243 | 213 | 185 | 148 | 117 | 95 | 84 |
| Net margin % | 22.6 | 23.3 | 22.7 | 20.8 | 19.6 | 16.2 | 13.5 | 13.8 |
| EPS (₹) | 52.47 | 47.44 | 41.49 | 36.18 | 28.96 | 23.63 | 19.15 | 16.86 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3314 | 2349 | 2065 | 2077 | 1453 | 1179 | 1062 | 996 |
| Net profit | 664 | 289 | 270 | 375 | 263 | 258 | 409 | 149 |
| Net margin % | 20.0 | 12.3 | 13.1 | 18.1 | 18.1 | 21.8 | 38.5 | 15.0 |
| EPS (₹) | 129.48 | 58.19 | 54.57 | 75.69 | 53.09 | 52.02 | 82.57 | 30.15 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 16.7% in Mar 2026; debt to equity is 0.31.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 16.7 | 11.0 | 11.3 | 17.2 |
| Return on capital % | 18.7 | 11.7 | 11.7 | 17.4 |
| EBITDA margin % | 33.7 | 24.1 | 23.9 | 27.7 |
| Net margin % | 19.6 | 12.1 | 12.8 | 17.8 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 16.9% | 21.8% |
| Profit CAGR | 20.9% | 20.8% |
4 · The owners
Who holds it, and are they adding?
Down 1.36 pts over 8 quarters.
Up 4.83 pts over 8 quarters.
Up 0.24 pts over 8 quarters.
+53 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 28.44 | 28.44 | 28.01 | 27.12 | 27.11 | 27.11 | 27.08 | 27.08 | -1.36 |
| FII | 18.55 | 20.16 | 21.55 | 22.15 | 23.74 | 23.78 | 23.73 | 23.38 | +4.83 |
| DII | 28.46 | 30.04 | 28.71 | 29.57 | 28.09 | 27.62 | 28.46 | 28.7 | +0.24 |
| Public | 24.55 | 21.36 | 21.73 | 21.16 | 21.06 | 21.49 | 20.73 | 20.85 | -3.7 |
Mutual fund holdings · Oct 2026
233 schemes hold this stock
180 the month before.
- Kotak Nifty Chemicals ETF9.66% of NAV
- Groww Nifty Chemicals ETF9.65% of NAV
- Invesco India Nifty Chemical Index Fund9.48% of NAV
- UNION FOCUSED FUND4.74% of NAV
- Axis Momentum Fund4.74% of NAV
- SBI Long Term Advantage Fund - Series IV4.44% of NAV
- SAMCO SMALL CAP FUND4.0% of NAV
- SBI Long Term Advantage Fund - Series V3.98% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for NAVIN FLUORI are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about NAVIN FLUORI
What is the NAVIN FLUORI share price?
NAVIN FLUORI (NAVINFLUOR) last closed at ₹10,203.00, down 0.73% on the day. Its 52-week range is ₹5,563.00 to ₹10,278.00.
What is the market cap of NAVIN FLUORI?
NAVIN FLUORI has a market capitalisation of about ₹52,626 crore. Its price-to-earnings ratio is 58.1.
How are NAVIN FLUORI's latest results?
NAVIN FLUORI reported revenue of ₹1,191 crore for Sep 2026, up 57.1% from a year earlier. Net profit was ₹269 crore (up 81.8% year on year). Return on equity was 16.7% in Mar 2026. Promoter holding was 27.08% in Sep 2026, down 1.36 points over 8 quarters.
Who owns NAVIN FLUORI?
As of Sep 2026, shareholding was: Promoter 27.08%, FII 23.38%, DII 28.7%, Public 20.85%.
How many mutual funds hold NAVIN FLUORI?
233 mutual fund schemes held NAVIN FLUORI in October 2026. That compares with 180 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 12 Jun 2026 · Final Dividend - Rs. 8.6
- 07 Nov 2025 · Interim Dividend - Rs. 6.5
- 04 Jul 2025 · Final Dividend - Rs. 7
- 07 Nov 2024 · Interim Dividend - Rs. 5
- 05 Jul 2024 · Final Dividend - Rs. 7
- 10 Nov 2023 · Special Dividend - Rs. 3
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.